Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCI699 Phase III Trial in Cushing's Disease
CTR20160563Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of osilodrostat in Corticotropin adenoma (ACTHoma), sponsored by Novartis. Started Sep 2016; status: completed.
02
Drugs
osilodrostat
03
Conditions
Corticotropin adenoma (ACTHoma)
Beyond the preview
Go deeper on CTR20160563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160563.